An experimental Alzheimer’s treatment slowed mental decline in patients with early stages of the disease by 34 percent, the first evidence that a medication may be able to alter the course of the disease, according to research presented by scientists meeting in Boston on Monday.
Scientists were quick to note that the results they found in their analysis of the drug, known as Solanezumab, were modest and that much more study needs to be done to confirm that the medication truly is effective.
Comments
For another angle on prevention and intervention, see Haley and Russell's Oct. 6th op-ed in MetroWest Daily News, on how mercury causes neurofibrillary tangles just as in Alzheimer's, and leads to brain and CNS damage that can present as, exacerbate, and be a causative factor in the condition. Like most chronic diseases, inflammation and damage is brought on by a combination of nature (genes), nurture (foods from mother's milk to Ensure, upbringing, behavior, exercise, habits, lifestyle, etc.) and exposures to toxins and pathogens, which our bodies, brains, cells, membranes and nerves are not equipped to handle. Think of heavy metals and other toxins as foreign invaders to our "operating system" that cause it to go awry, malfunction and cause chronic, costly, devastating diseases like Alzheimer's. One of the causes and contributing factors is hiding in plain sight, dental amalgam, which has been proven to off-gas toxic mercury vapors that is especially harmful to people with the ApoE4 gene, who do not clear mercury well. Hidden River Cloud Network/One Challenge invites people of all ages, stages and walks of life, families, concerned employers, schools and colleges, civic, religious and nonprofit organizations, researchers and scientists, dentists and doctors, health professionals and first responders, tradespeople and service workers, lawyers and accountants, public officials and public policy professionals, journalists and artists to join together in the coming year to focus on a common challenge, SafeAMER: educating, engaging and exploring the issues, risks, and safer alternatives to mercury amalgam in dentistry. This is important work. Accelerate it. We now know enough to run, not walk, to end Alzheimer's.